BioStar Ventures is a strategic venture capital partnership focused on accelerating value creation for medical device and connected health technologies in cardiovascular and orthopaedic medicine.
Combining the insight of seasoned venture capitalists and world-renowned medical thought leaders, BioStar Ventures identifies proprietary technologies that meet unmet patient needs, as well as the acquisition criteria of major medical device companies, and then acts as a true value-added investor, providing both capital and clinical expertise to mitigate risk, optimize product development and secure successful exit.
BioStar Ventures fills an important funding gap in translational medical device development, making initial investments up to $1 million and typically from $2 to $6 million over the life of an investment.
The firm has invested in more than 30 seed or early-stage companies, nearly half of which have already been acquired by leading medical device manufacturers.
560 W. Mitchell Street, Suite 480
49770 United States